Skip to main content
. Author manuscript; available in PMC: 2010 Apr 8.
Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2008 Apr 16;78(4-5):247–255. doi: 10.1016/j.plefa.2008.01.008

Fig. 2.

Fig. 2

Effect of PKA inhibitor (PKA I; 14-22 amide peptide sequence) or PKG inhibitor (PKG I; DT-3 peptide) on the acute inhibition of O2⋅− formation by hVSMCs pre-incubated for 16 h with 100 nM U46619 (100 nM) by (A) iloprost (100 ng/ml) and (B) NONOate (10 μM). Each point = mean±S.E.M., n = 6. *P<0.01, significantly increased compared to iloprost alone. †P<0.01, significantly increased compared to NONOate alone.